Sean J. Pittock
Correspondence & reprint requests to Dr. Pittock:
Name/email consistency: high
- Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays. Waters, P.J., McKeon, A., Leite, M.I., Rajasekharan, S., Lennon, V.A., Villalobos, A., Palace, J., Mandrekar, J.N., Vincent, A., Bar-Or, A., Pittock, S.J. Neurology (2012)
- Paraneoplastic isolated myelopathy: Clinical course and neuroimaging clues. Flanagan, E.P., McKeon, A., Lennon, V.A., Kearns, J., Weinshenker, B.G., Krecke, K.N., Matiello, M., Keegan, B.M., Mokri, B., Aksamit, A.J., Pittock, S.J. Neurology (2011)
- Neural autoantibody evaluation in functional gastrointestinal disorders: a population-based case-control study. Pittock, S.J., Lennon, V.A., Dege, C.L., Talley, N.J., Locke, G.R. Dig. Dis. Sci. (2011)
- Paraneoplastic jaw dystonia and laryngospasm with antineuronal nuclear autoantibody type 2 (anti-Ri). Pittock, S.J., Parisi, J.E., McKeon, A., Roemer, S.F., Lucchinetti, C.F., Tan, K.M., Keegan, B.M., Hunter, S.F., Duncan, P.R., Baehring, J.M., Matsumoto, J.Y., Lennon, V.A. Arch. Neurol. (2010)
- Benign multiple sclerosis: a distinct clinical entity with therapeutic implications. Pittock, S.J., Rodriguez, M. Curr. Top. Microbiol. Immunol. (2008)
- Neuromyelitis optica: a new perspective. Pittock, S.J. Semin. Neurol (2008)
- Interferon beta in multiple sclerosis: how much BENEFIT?. Pittock, S.J. Lancet (2007)
- Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Pittock, S.J., Yoshikawa, H., Ahlskog, J.E., Tisch, S.H., Benarroch, E.E., Kryzer, T.J., Lennon, V.A. Mayo Clin. Proc. (2006)
- Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Pittock, S.J., Weinshenker, B.G., Lucchinetti, C.F., Wingerchuk, D.M., Corboy, J.R., Lennon, V.A. Arch. Neurol. (2006)
- Inflammatory transverse myelitis: evolving concepts. Pittock, S.J., Lucchinetti, C.F. Curr. Opin. Neurol. (2006)
- A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke. Pittock, S.J., Moore, A.P., Hardiman, O., Ehler, E., Kovac, M., Bojakowski, J., Al Khawaja, I., Brozman, M., Kanovský, P., Skorometz, A., Slawek, J., Reichel, G., Stenner, A., Timerbaeva, S., Stelmasiak, Z., Zifko, U.A., Bhakta, B., Coxon, E. Cerebrovasc. Dis. (2003)
- Patient and hospital delays in acute ischaemic stroke in a Dublin teaching hospital. Pittock, S.J., Meldrum, D., Hardiman, O., Deane, C., Dunne, P., Hussey, A., Gorman, M., Moroney, J.T. Ir. Med. J (2003)
- The Orpington Prognostic Scale within the first 48 hours of admission as a predictor of outcome in ischemic stroke. Pittock, S.J., Meldrum, D., Ni Dhuill, C., Hardiman, O., Moroney, J.T. J. Stroke. Cerebrovasc. Dis (2003)
- Reversible myelopathy in a 34-year-old man with vitamin B12 deficiency. Pittock, S.J., Payne, T.A., Harper, C.M. Mayo Clin. Proc. (2002)
- Evaluation of stroke management in an Irish university teaching hospital: the Royal College of Physicians stroke audit package. Pittock, S.J., Hardiman, O., Goode, B., Moroney, J.T. Ir. J. Med. Sci (2001)